|
Research Management and Support
|
RMS2009 [E]
|
$350,982,837
|
$4,192,000
|
N/A
|
National Cancer Institute
|
|
Infections, immunity, and inflammation in cancer
|
ZIA CP010150-10290
|
$21,722
|
$21,722
|
A Engels, Eric
|
DCEG (NCI)
|
|
Leadership Component in Chemoprevention: Mouse Models of Human Cancer Consortium
|
1U01CA141535-01
|
$410,000
|
$410,000
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Elucidation of cancer pathways and druggable targets using mouse models.
|
2U01CA084294-11
|
$835,000
|
$835,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Modeling androgen-independent prostate cancer in mutant mice
|
5R01CA115717-03
|
$305,900
|
$305,900
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Modeling Prostate Tumorigenesis
|
5R01CA094858-07
|
$230,554
|
$230,554
|
Abdulkadir, Sarki
|
VANDERBILT UNIVERSITY
|
|
Role of Oncogenic Kinase Pim-1 in Prostate Cancer
|
5R01CA123484-03
|
$291,406
|
$291,406
|
Abdulkadir, Sarki
|
VANDERBILT UNIVERSITY
|
|
CANCER INFORMATION SERVICE
|
N02CO511001-012
|
$1,675,013
|
$184,251
|
ABIDI, SYED
|
SLOAN KETTERING INSTITUTION FOR CANCER R
|
|
Prostate Cancer Prevention and Treatment by Silibinin
|
2R01CA102514-06
|
$334,007
|
$334,007
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Prostate Cancer Prevention by Procyanidins in Grape Seed Extract
|
5R01CA091883-07
|
$333,644
|
$333,644
|
AGARWAL, CHAPLA
|
UNIVERSITY OF COLORADO DENVER
|
|
Prostate Cancer Chemoprevention by Inositol Hexaphosphate Efficacy and Mechanism
|
5R01CA116636-04
|
$261,235
|
$261,235
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Role of NCoR in Antiandrogen Resistance in Prostate Cancer
|
5R21CA129265-02
|
$172,688
|
$172,688
|
AGOULNIK, IRINA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
4R44CA124032-02
|
$1,473,388
|
$1,473,388
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
SELECT Pre-Clinical Trial of Prostate Cancer
|
5R01CA114060-04
|
$250,774
|
$250,774
|
Ahmad, Nihal
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Phase III Trial of Selenium for Prostate Cancer Prevention
|
5R01CA077789-11
|
$607,234
|
$607,234
|
Ahmann, Frederick
|
UNIVERSITY OF ARIZONA
|
|
Methylated Galectin-3 DNA as a Marker for Early Diagnosis of Prostate Cancer
|
1R03CA133935-01A2
|
$75,000
|
$75,000
|
AHMED, HAFIZ
|
UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-06
|
$238,147
|
$4,763
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
North Carolina A&T University-Wake Forest Cancer Center partnership (2 of 2)
|
5P20CA138018-02
|
$103,226
|
$25,807
|
AKMAN, STEVEN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$774,176
|
$77,418
|
Alavanja
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195-03031
|
$804,186
|
$201,047
|
Albanes
|
DCEG (NCI)
|
|
Comprehensive MRI, MRS and Molecular Analyses: Pten-based Prostate Cancer Models
|
5R01CA129003-03
|
$291,650
|
$291,650
|
ALBANESE, CHRISTOPHER
|
GEORGETOWN UNIVERSITY
|
|
Clinical Academic Oncologist Training Program
|
5K12CA087718-10
|
|
$0
|
Albertini, Mark
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
2P30CA023074-31
|
$4,161,907
|
$249,714
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-31S1
|
$105,806
|
$6,348
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Cancer Prevention and Control Training Grant
|
5R25CA078447-10
|
$511,052
|
$102,210
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
CNP for Older Underserved African American Adults
|
3U01CA114583-05S1
|
$83,530
|
$20,883
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
CNP for Older Underserved African American Adults
|
5U01CA114583-05
|
$184,349
|
$46,087
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
CANCER INFORMATION SERVICE
|
N02CO511003-007
|
$614,862
|
$67,635
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIV:1107401
|
|
Assessing Localized Prostate Cancer Post-Treatment Outcomes Among Gay Men
|
1R03CA136114-01A1
|
$81,250
|
$81,250
|
Allensworth-Davies, Donald
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Molecular targeting of the survivin pathway in cancer
|
5R01CA090917-10
|
$288,775
|
$14,439
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Maryland Prostate Cancer Case-Control Study
|
ZIA BC 010499
|
$567,829
|
$567,829
|
Ambs, Stefan
|
CCR (NCI)
|
|
The Molecular Profile of Prostate Tumors in African-American Men
|
ZIA BC 010624
|
$354,893
|
$354,893
|
Ambs, Stefan
|
CCR (NCI)
|
|
The Molecular Profile of Prostate Tumors in Smokers
|
ZIA BC 010660
|
$141,957
|
$141,957
|
Ambs, Stefan
|
CCR (NCI)
|
|
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer
|
ZIA BC 010886
|
$212,936
|
$212,936
|
Ambs, Stefan
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$728,095
|
$36,405
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING
|
N01CN025516-095
|
$1,562,516
|
$390,629
|
ANDRIOLE, GERALD
|
WASHINGTON UNIV:1107522
|
|
Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agent
|
5K99CA131489-02
|
$132,965
|
$66,483
|
Aneja, Ritu
|
GEORGIA STATE UNIVERSITY
|
|
Extension of Radiotherapy Research
|
3P01CA006294-44S1
|
$300,000
|
$30,000
|
ANG, K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
ADD ARTICLE H.49., EXCHANGE OF CONFIDENTIAL INFORMATION AND RESEARCH MATERIALS
|
N01CO800001-012
|
$231,187,932
|
$9,751,832
|
ARTHUR, LARRY
|
SAIC-FREDERICK INC:1107088
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-23
|
$2,304,698
|
$345,705
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
$2,617
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
5R01CA077091-06
|
$346,857
|
$69,371
|
Au, Jessie
|
OPTIMUM THERAPEUTICS, LLC
|
|
Explosive Evolution Under Stress: The Driving Forces of Cancer Dynamics (Main)
|
1U54CA143803-01
|
$3,008,880
|
$752,220
|
AUSTIN, ROBERT
|
PRINCETON UNIVERSITY
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-35
|
$417,370
|
$8,347
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
5U10CA052667-19
|
$687,330
|
$75,606
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
|
N01CN035153-010
|
$1,664,000
|
$332,800
|
BAILEY, HOWARD
|
WISCONSIN UNIV:1107444
|
|
Psycho-sociocultural factors influencing cancer pain management in elderly adults
|
1K01CA131722-01A1
|
$130,943
|
$32,736
|
BAKER, TAMARA
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Southwest Oncology Group
|
5U10CA027057-30
|
$267,015
|
$18,691
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-30
|
$9,379,270
|
$656,549
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-25
|
$10,708,109
|
$1,392,054
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
Total relevant funding to Prostate for this search: $293,932,674
|